False‑Positive Lab Result Sparks Confusion: How Taylor Farms Dragged Its Feet While the FDA Scrambled to Fix a Cyclosporiasis Outbreak

In early July, the U.S. Food and Drug Administration announced that a laboratory test had mistakenly flagged a batch of Taylor Farms iceberg lettuce as the source of a massive cyclosporiasis outbreak. The error, later labeled a false positive, set off a cascade of headlines, a confusing recall notice, and a public apology that the agency soon seemed to backtrack on.

Taylor Farms, one of the country’s largest salad producers, responded on X (formerly Twitter) with a terse statement apologizing for the mix‑up. Within a day, the post vanished, and the company fell silent as the story unfolded. Observers noted the timing—just as the FDA was wrestling with how to correct the record—was no coincidence.

Cyclosporiasis, caused by the parasite Cyclospora cayetanensis, can provoke severe, watery diarrhea and has hospitalized more than 300 people in the current wave. The outbreak, centered in the Midwest but traced to shipments from central Mexico, is the worst the nation has seen in decades.

When the FDA first announced that testing linked Taylor Farms’ lettuce to the outbreak, the company missed a regulator‑set deadline to initiate a recall. By the time the agency clarified that the initial lab result was a false positive, the damage was already done: consumers were bewildered, grocery shelves were half‑emptied, and health officials accused the firm of “obfuscating” the science.

“One laboratory test produced a false‑positive result for a shipment of Taylor Farms lettuce that was outside the scope of the current recall, and FDA promptly notified the company after receiving that result,” Health and Human Services spokesperson Emily Hilliard said. She added that the corrected result did not change the agency’s overall determination that the outbreak required continued monitoring.

Yet the narrative on the ground was anything but clear. Former FDA Center for Food Safety and Applied Nutrition director Susan Mayne described the recall notice as “perhaps the most obtuse recall notice I recall ever seeing.” She pointed to the back‑and‑forth between the company, the White House, and the FDA, which she said added roughly 60 hours of uncertainty for the public.

Inside sources — who asked not to be named because they lack clearance to discuss private conversations — said Taylor Farms pushed back on the science privately while publicly spinning confusing messages. The company claimed it had met with FDA and White House officials “to discuss the best approach to ensure public health,” but declined further comment.

At the heart of the issue is a broader question about food‑safety oversight in an increasingly global supply chain. When a single lab error can trigger a nationwide recall, the stakes are high for both producers and regulators. Critics argue that the FDA needs more robust verification steps before publicly linking a brand to a public‑health crisis.

For now, the outbreak continues to be monitored, and consumers are urged to stay informed through official channels. Taylor Farms has pledged to cooperate fully with authorities, but the episode has left a sour taste—literally and figuratively—for shoppers who trusted the brand’s “freshness” promise.